Published in Infect Immun on November 01, 1991
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol (1993) 8.95
Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa. Proc Natl Acad Sci U S A (2002) 2.66
Cloning and nucleotide sequence analysis of the ferripyoverdine receptor gene fpvA of Pseudomonas aeruginosa. J Bacteriol (1993) 2.17
Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev (1999) 1.83
Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa. J Bacteriol (2006) 1.80
This is not your mother's repressor: the complex role of fur in pathogenesis. Infect Immun (2009) 1.71
Gene expression in Pseudomonas aeruginosa: evidence of iron override effects on quorum sensing and biofilm-specific gene regulation. J Bacteriol (2001) 1.47
Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest (1992) 1.44
Nucleotide sequence of pvdD, a pyoverdine biosynthetic gene from Pseudomonas aeruginosa: PvdD has similarity to peptide synthetases. J Bacteriol (1995) 1.42
Iron-regulated transcription of the pvdA gene in Pseudomonas aeruginosa: effect of Fur and PvdS on promoter activity. J Bacteriol (1996) 1.41
Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2009) 1.40
Homeostatic interplay between bacterial cell-cell signaling and iron in virulence. PLoS Pathog (2010) 1.22
Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infect Immun (1994) 1.21
Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun (1997) 1.19
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. MBio (2014) 1.18
The pvc gene cluster of Pseudomonas aeruginosa: role in synthesis of the pyoverdine chromophore and regulation by PtxR and PvdS. J Bacteriol (1999) 1.14
Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol (2004) 1.13
Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun (2013) 1.05
Microbial telesensing: probing the environment for friends, foes, and food. Cell Host Microbe (2009) 1.03
Long-term social dynamics drive loss of function in pathogenic bacteria. Proc Natl Acad Sci U S A (2015) 1.03
Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Infect Immun (1997) 1.02
Factors affecting catalase expression in Pseudomonas aeruginosa biofilms and planktonic cells. Appl Environ Microbiol (2001) 0.94
Involvement of AlgQ in transcriptional regulation of pyoverdine genes in Pseudomonas aeruginosa PAO1. J Bacteriol (2005) 0.92
FpvA receptor involvement in pyoverdine biosynthesis in Pseudomonas aeruginosa. J Bacteriol (2002) 0.90
Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media. Infect Immun (1997) 0.90
Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth. Infect Immun (1996) 0.90
Role of cell surface signaling in proteolysis of an alternative sigma factor in Pseudomonas aeruginosa. J Bacteriol (2008) 0.83
Degradation pathway and generation of monohydroxamic acids from the trihydroxamate siderophore deferrioxamine B. Appl Environ Microbiol (2004) 0.83
Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa. Infect Immun (2014) 0.82
Insertion mutagenesis of the ferric pyoverdine receptor FpvA of Pseudomonas aeruginosa: identification of permissive sites and a region important for ligand binding. J Bacteriol (1998) 0.82
Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection. Sci Rep (2016) 0.82
Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients. Front Microbiol (2015) 0.79
Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection. BMC Genomics (2015) 0.75
Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med (1954) 63.14
Universal chemical assay for the detection and determination of siderophores. Anal Biochem (1987) 18.60
Microbial iron compounds. Annu Rev Biochem (1981) 10.11
Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry (1968) 2.65
Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun (1985) 2.38
Iron metabolism in humans and plants. Am Sci (1983) 1.85
Systemic virulence of Erwinia chrysanthemi 3937 requires a functional iron assimilation system. J Bacteriol (1988) 1.63
Siderochromes from Pseudomonas fluorescens. I. Isolation and characterization. J Biol Chem (1982) 1.59
Isolation of enterochelin from the peritoneal washings of guinea pigs lethally infected with Escherichia coli. Infect Immun (1980) 1.46
Molecular cloning and expression of genetic determinants for the iron uptake system mediated by the Vibrio anguillarum plasmid pJM1. J Bacteriol (1984) 1.46
Plasmids mediating iron uptake in Vibrio anguillarum strains isolated from turbot in Spain. J Gen Microbiol (1985) 1.39
Surface expression of ferripyochelin-binding protein is required for virulence of Pseudomonas aeruginosa. Infect Immun (1987) 1.21
[Pyoverdin-type siderophores from Pseudomonas aeruginosa]. Z Naturforsch C (1986) 1.15
Anaerobic iron uptake by Escherichia coli. J Bacteriol (1984) 0.97
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science (1994) 5.57
Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry (1997) 5.46
Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem (1977) 5.37
Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c. Science (1992) 4.82
Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry (1997) 4.55
Small-bowel changes in dermatitis herpetiformis. Lancet (1966) 4.49
Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism. Science (1994) 4.11
Structure of subtilisin BPN' at 2.5 angström resolution. Nature (1969) 3.98
Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem (1982) 3.84
Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem (1985) 2.95
Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Coeliac syndrome in dermatitis herpetiformis. Lancet (1968) 2.73
Ending the routine guinea-pig test. Tubercle (1972) 2.56
Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. J Biol Chem (1984) 2.56
Low-resolution electron-density and anomalous-scattering-density maps of Chromatium high-potential iron protein. J Mol Biol (1968) 2.46
Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPH. J Biol Chem (1982) 2.45
The stereochemistry of peroxidase catalysis. J Biol Chem (1980) 2.35
Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys (1995) 2.28
Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity. Biochemistry (1996) 2.25
Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation. Biochemistry (1970) 2.23
Subtilisin; a stereochemical mechanism involving transition-state stabilization. Biochemistry (1972) 2.13
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis (2005) 2.11
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
A system for the examination of tubercle bacilli and other mycobacteria. Tubercle (1976) 2.00
Purpura associated with vomiting in pregnancy. Br Med J (1973) 1.98
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res (2001) 1.95
Dihydrofolate reductase from Lactobacillus casei. X-ray structure of the enzyme methotrexate.NADPH complex. J Biol Chem (1978) 1.94
A comparison of Fe 4 S 4 clusters in high-potential iron protein and in ferredoxin. Proc Natl Acad Sci U S A (1972) 1.93
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Directed mutagenesis of dihydrofolate reductase. Science (1983) 1.88
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet (1979) 1.87
Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry (1991) 1.86
Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase beta. J Biol Chem (1996) 1.85
X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state. J Biol Chem (1975) 1.82
The S. pombe cdc16 gene is required both for maintenance of p34cdc2 kinase activity and regulation of septum formation: a link between mitosis and cytokinesis? EMBO J (1993) 1.80
Cell kinetics in flat (avillous) mucosa of the human small intestine. Gut (1973) 1.76
Opium, the religion of the people. Lancet (1985) 1.74
The structure of oxidized cytochrome c 2 of Rhodospirillum rubrum. J Biol Chem (1973) 1.73
Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. Biochemistry (1990) 1.71
Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis. Science (1986) 1.68
Small intestine in psoriasis. Br Med J (1967) 1.66
Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry (1990) 1.66
Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J Biol Chem (1985) 1.62
Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis (1971) 1.62
Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. II. Environment of bound NADPH and implications for catalysis. J Biol Chem (1982) 1.61
Classification of Mycobacterium avium and related opportunist mycobacteria met in England and Wales. J Hyg (Lond) (1967) 1.61
Orbital rhabdomyosarcoma. An analysis of 62 cases. Am J Ophthalmol (1966) 1.60
Two-Angstrom crystal structure of oxidized Chromatium high potential iron protein. J Biol Chem (1974) 1.55
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Mycobacterium szulgai--a new pathogen. Tubercle (1972) 1.49
Small-intestinal mucosal abnormalities in various skin diseases--fact or fancy? Gut (1970) 1.46
Occupation and Kansasii infection in Cardiff residents. Tubercle (1975) 1.45
A structural basis for metal ion mutagenicity and nucleotide selectivity in human DNA polymerase beta. Biochemistry (1996) 1.45
A hypothetical model of the cytochrome c peroxidase . cytochrome c electron transfer complex. J Biol Chem (1980) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'. Biochemistry (1972) 1.44
Thin-layer chromatography of mycobacterial lipids as an aid to classification: technical improvements: mycobacterium avium, M. intracellulare (Battey bacilli). Tubercle (1971) 1.43
A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma (2004) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Effect of exercise on milk immunoglobulin A. Med Sci Sports Exerc (1997) 1.39
A proposed model for interaction of polypeptides with RNA. Proc Natl Acad Sci U S A (1974) 1.39
Intraabdominal mesh prosthesis in a canine model. Surg Endosc (1994) 1.38
Atomic coordinates for subtilisin BPN' (or Novo). Biochem Biophys Res Commun (1971) 1.37
The cell cycle time in the flat (avillous) mucosa of the human small intestine. Gut (1973) 1.37
Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal. Hernia (2007) 1.36
Structural bases for function in cytochromes c. An interpretation of comparative x-ray and biochemical data. J Biol Chem (1973) 1.36
Harm minimisation for drug misusers. BMJ (1992) 1.35
The crystal structure of cytochrome c peroxidase. J Biol Chem (1980) 1.35
Thin-layer chromatography of mycobacterial lipids as an aid to classification; Mycobacterium kansasii; and Mycobacterium marinum (balnei). Tubercle (1966) 1.35
Heterotrophic nitrification among denitrifiers. Appl Environ Microbiol (1984) 1.34
HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. Lancet (1973) 1.34
Improvement of drg-sensitivity tests on tubercle bacilli. Tubercle (1970) 1.31
Structure of the iron-sulfur cluster in the Chromatius iron protein at 2.25 Angstrom resolution. Cold Spring Harb Symp Quant Biol (1972) 1.30
Crystal structure of a novel trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. Biochemistry (1986) 1.29
Mycobacterium szulgai-a new pathogen. Serologic identification and report of five new cases. Am Rev Respir Dis (1973) 1.29
The activity of S.pombe DSC-1-like factor is cell cycle regulated and dependent on the activity of p34cdc2. EMBO J (1993) 1.29
"How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research. Hosp Health Serv Adm (1994) 1.26
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25
Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine- and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisin. J Biol Chem (1976) 1.25
The opportunist mycobacteria--a 20-year retrospect. Postgrad Med J (1971) 1.24
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J Virol (1987) 1.24
"Capillary permeability" in patients with collagen vascular diseases. Br Med J (1972) 1.24
Folic acid deficiency in patients with skin disease. Br J Dermatol (1967) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Effect of PUVA on serum 25-OH vitamin D in psoriatics. Br Med J (1979) 1.21
An engineered disulfide bond in dihydrofolate reductase. Biochemistry (1987) 1.20
Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut (2007) 1.20
Infection with the avian-Battey group of mycobacteria in England and Wales. Br Med J (1969) 1.19
Determination by Raman spectroscopy of the pKa of N5 of dihydrofolate bound to dihydrofolate reductase: mechanistic implications. Biochemistry (1994) 1.18
Dihydrofolate reductase. The stereochemistry of inhibitor selectivity. J Biol Chem (1985) 1.17
Vertebrate p34cdc2 phosphorylation site mutants: effects upon cell cycle progression in the fission yeast Schizosaccharomyces pombe. J Cell Sci (1992) 1.16
Pilonidal sinus excision--healing by open granulation. Br J Surg (1985) 1.15
Histidine 52 is a critical residue for rapid formation of cytochrome c peroxidase compound I. Biochemistry (1993) 1.15